SCHEMBL6603885

SCHEMBL6603885

COc1ccc(-c2ccc3c(c2)C(=O)NC3=O)c2c1OCCO2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STK10 O94804 2/20 0.45
SLK Q9H2G2 2/20 0.45
KDM4E B2RXH2 2/20 0.43
LMNA P02545 2/20 0.43
ALDH1A1 P00352 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP2 O95551 2/20 0.43
CHEK1 O14757 4/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
GPR55 Q9Y2T6 1/20 0.39
MAPT P10636 1/20 0.38
PTPRC P08575 1/20 0.38
PTPN1 P18031 1/20 0.38
CASP3 P42574 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6604245 0.77 HSD17B1 (0.50) KDM4ELMNAALDH1A1HSD17B10TDP2
SCHEMBL6606519 0.75 HSD17B1 (0.60) KDM4ELMNAALDH1A1HSD17B10MAOA
SCHEMBL6605919 0.75 HSD17B1 (0.57) KDM4ELMNAALDH1A1HSD17B10MAOA
SCHEMBL6602481 0.75 KDM4E (0.56) KDM4ELMNAALDH1A1HSD17B10CHEK1
SCHEMBL6836428 0.72 LMNA (0.52) KDM4ELMNAALDH1A1HSD17B10
SCHEMBL15988845 0.72 KDM4E (0.66) KDM4ELMNAALDH1A1HSD17B10MEN1
SCHEMBL6604621 0.70 LMNA (0.50) KDM4ELMNAALDH1A1HSD17B10MEN1
SCHEMBL8962219 0.68 PPOX (0.60) TDP2MAOAMAOBCASP3
SCHEMBL8319902 0.68 PPOX (0.60) TDP2MAOAMAOBCASP3
SCHEMBL6837558 0.68 MAPT (0.48) KDM4ELMNAALDH1A1HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1110961-B1 OXYGENIC HETEROCYCLIC COMPOUNDS KYOWA HAKKO KOGYO KK (JP) 2004-07-14 EP disclosed
US-6376535-B2 PHOSPHODIESTERASE (PDE) INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-04-23 US disclosed
US-20010056117-A1 Oxygen-containing heterocyclic compounds KYOWA HAKKO KIRIN CO., LTD. (JP) 2001-12-27 US disclosed
EP-1110961-A1 OXYGENIC HETEROCYCLIC COMPOUNDS KYOWA HAKKO KOGYO CO., LTD. (JP) 2001-06-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010056117-A1 Oxygen-containing heterocyclic compounds CBR1, CBR3, MT-CO1 STK10 1824/4885SLK 3304/4885KDM4E 444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.